Broxyquinoline

An association with exercise intolerance has been reported.[1]

Broxyquinoline

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	A07AX01 (WHO) G01AC06 (WHO) P01AA01 (WHO)
Identifiers
IUPAC name 5,7-Dibromoquinolin-8-ol
CAS Number	521-74-4^Y
PubChem CID	2453
ChemSpider	2359^N
UNII	UK4C618C8T
ChEMBL	ChEMBL223448^N
CompTox Dashboard (EPA)	DTXSID9045849
ECHA InfoCard	100.007.563
Chemical and physical data
Formula	C9H5Br2NO
Molar mass	302.953 g·mol^−1
3D model (JSmol)	Interactive image
SMILES Brc1c(O)c2ncccc2c(Br)c1
InChI InChI=1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H^N Key:ZDASUJMDVPTNTF-UHFFFAOYSA-N^N
^NY (what is this?)  (verify)

Broxyquinoline is an antiprotozoal agent.

References

1. Swain R, Bapna JS (January 1986). "Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination". Human Toxicology. 5 (1): 63–4. doi:10.1177/096032718600500115. PMID 3081430.